A Study to Evaluate the Safety and Efficacy of Selinexor With or Without Pembrolizumab Versus Standard of Care in Previously Treated Metastatic Colorectal Cancer With RAS Mutations
Clinical trial NCT04854434 · TERMINATED
Trial details
- NCT number
- NCT04854434
- Sponsor
- Karyopharm Therapeutics Inc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-29
- Primary completion
- 2022-06-24
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.